Epicor Named as a Visionary in Gartner® 2021 Magic Quadrant™

For the third consecutive year, the Gartner report recognizes Epicor for its vision and execution Austin, Texas, Aug. 27, 2021 (GLOBE NEWSWIRE) — Epicor Software Corporation, a global provider of industry-specific enterprise software to promote business growth, has been named a Visionary in the 2021 Gartner Magic Quadrant for Cloud ERP for Product-Centric Enterprisesi  for the third consecutive […]

Continue Reading

ImmunoBrain Checkpoint Awarded $5 Million US NIA Grant for Phase 1b Alzheimer’s Disease Proof-of-Mechanism Study of Anti-PD-L1 IBC-Ab002

ImmunoBrain Checkpoint Awarded $5 Million US NIA Grant for Phase 1b Alzheimer’s Disease Proof-of-Mechanism Study of Anti-PD-L1 IBC-Ab002 NEW YORK, Friday August 27, 2021 – ImmunoBrain Checkpoint Inc. (“IBC”) an innovative biopharmaceutical company developing potential disease-modifying immune therapies that harness the power of the immune system to help protect and repair the brain to combat […]

Continue Reading

Junshi Biosciences Announces Acceptance by NMPA of Investigational New Drug Application for the Subcutaneous Injection of Anti-BLyS Monoclonal Antibody

SHANGHAI, China, Aug. 27, 2021 (GLOBE NEWSWIRE) — Junshi Biosciences (HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced today that the National Medical Products Administration (NMPA) of China has accepted an investigational new drug application for UBP1213sc, its subcutaneous injection of recombinant humanized […]

Continue Reading